MUNICH–(COMMERCIAL THREAD) – The winner of the “La Tablette d’Or” award®“was determined – BioNTech. In addition to the research activity of the company, a large product pipeline with many innovations is decisive for the price, as well as the quality of the products. The ranking” Best Pharmaceutical Companies Germany 2021 “has also been published: Roche Pharma, Lilly, Bristol-Myers Squibb, Novartis Pharma and Amgen occupy places 1 to 5 in the Pharma Trend Image & Innovation Award survey.
Thirteen other winners were able to take advantage of the “Most innovative product” award. These include in the Rx category (prescription drugs): the COVID-19 vaccine Comirnaty® from BioNTech and Tolak® for the treatment of actinic keratosis from Pierre Fabre. Exeltis is awarded both for oral contraceptive Slinda® and DeflaGyn® for the treatment of cervical dysplasia / erosions. In the Orphan Drugs category, the hepatitis D drug from Gilead Sciences Hepcludex®, Poteligeo® by Kyowa Kirin for the treatment of mycosis fungoides and Sézary syndrome, and Pemazyre d’Incyte® for the treatment of win cholangiocarcinoma.
In the specialist care segment, the prostate cancer drug Erleada® de Janssen-Cilag receives an award. The food supplement ImmunoBON® for Allergy Therapy by Bencard is the winner in the OTC category. Jenapharm’s MyIUS application, which supports users of intrauterine systems, was chosen in the Digital Health Applications category. Roche Diagnostics won in the Diagnostics category with the SARS-CoV-2 rapid antigen test on the one hand, and the Avenio NGS oncology test on the other. In the Leap Innovations – Treatment of COVID-19 category, Formycon comes in first place followed by Ethris and Pieris Pharmaceuticals in second and third places.
The publication of the ranking and the thematic awards ceremony took place on September 14, 2021 as a hybrid event in the Ehrensaal of the Deutsches Museum.
More information on ranking and awards at https://pharma-trend.com/en/pharma-award/